PAVmed (PAVM) Cash from Financing Activities (2015 - 2025)

PAVmed's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$2000.0 for Q3 2025.

• On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to -$2000.0 in Q3 2025; TTM through Dec 2025 was $5.6 million, a 84.6% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 82.13% from the prior year.
• Cash from Financing Activities retreated to -$2000.0 in Q3 2025 per PAVM's latest filing, from $2.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $60.1 million in Q4 2021 and bottomed at -$2000.0 in Q3 2025.
• The 5-year median for Cash from Financing Activities is $2.8 million (2025), against an average of $11.7 million.
• Across the five-year window, Cash from Financing Activities plunged 99.87% in 2022 and surged 7787.34% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at $60.1 million in 2021, then plunged by 99.87% to $80000.0 in 2022, then surged by 6510.0% to $5.3 million in 2023, then sank by 93.76% to $330000.0 in 2024, then slumped by 100.61% to -$2000.0 in 2025.
• Per Business Quant, the three latest PAVM Cash from Financing Activities figures stand at -$2000.0 (Q3 2025), $2.5 million (Q2 2025), and $3.1 million (Q1 2025).